Literature DB >> 29039424

Skin cancer: Propranolol limits melanoma recurrence.

David Killock.   

Abstract

Entities:  

Year:  2017        PMID： 29039424     DOI： 10.1038/nrclinonc.2017.170

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study.

Authors:  Vincenzo De Giorgi; Marta Grazzini; Silvia Benemei; Niccolò Marchionni; Edoardo Botteri; Elisabetta Pennacchioli; Pierangelo Geppetti; Sara Gandini
Journal:  JAMA Oncol       Date:  2018-02-08       Impact factor: 31.777
  1 in total
  3 in total

1.  Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity.

Authors:  Wei Li; Jielin Wan; Cuiyu Chen; Chengfang Zhou; Ping Liao; Qian Hu; Jiali Hu; Yang Wang; Yu Zhang; Cong Peng; Yuanfei Huang; Weihua Huang; Wei Zhang; Howard L Mcleod; Yijing He
Journal:  J Mol Med (Berl)       Date:  2022-07-27       Impact factor: 5.606

2.  Norepinephrine promotes glioma cell migration through up-regulating the expression of Twist1.

Authors:  Xue Wang; Ying Wang; Fang Xie; Zi-Tian Song; Zi-Qian Zhang; Yun Zhao; Shi-Da Wang; Hui Hu; Yan-Shu Zhang; Ling-Jia Qian
Journal:  BMC Cancer       Date:  2022-02-26       Impact factor: 4.430

Review 3.  Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration Missions.

Authors:  Brian E Crucian; Alexander Choukèr; Richard J Simpson; Satish Mehta; Gailen Marshall; Scott M Smith; Sara R Zwart; Martina Heer; Sergey Ponomarev; Alexandra Whitmire; Jean P Frippiat; Grace L Douglas; Hernan Lorenzi; Judith-Irina Buchheim; George Makedonas; Geoffrey S Ginsburg; C Mark Ott; Duane L Pierson; Stephanie S Krieger; Natalie Baecker; Clarence Sams
Journal:  Front Immunol       Date:  2018-06-28       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.